Impact of the expert consensus on polypharmacy and potentially inappropriate medication use in elderly lung cancer outpatients with multimorbidity: An interrupted time series analysis, 2016-2021.

Tian, Fangyuan; Chen, Zhaoyan; Tang, Rui; Feng, Qiyi; Wu, Fengbo

Tian, Fangyuan; Chen, Zhaoyan; Tang, Rui; Feng, Qiyi; Wu, Fengbo.

Afiliação

Tian F; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
Chen Z; Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Tang R; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
Feng Q; Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China.
Wu F; Precision Medicine Research Center, Sichuan Provincial Key Laboratory of Precision Medicine and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.

Front Pharmacol ; 13: 992394, 2022.

Article em En | MEDLINE | ID: mdl-36278193

Palavras-chave

elderly; lung cancer; polypharmacy; potentially inappropriate medication; trend

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google